Kiran Mazumdar Shaw Explains Biocon's Q1 Beat

  • 1:18
  • Published On: July 22, 2016
Cinema View
Embed

Kiran Mazumdar Shaw, chairman and managing director at Biocon, said Q1 performance of the company was supported by strong growth in biologics business.

Related Videos

"Historic Moment": Kiran Mazumdar-Shaw On Women's Quota Bill
September 19, 2023 4:19
"Much Needed, Was Long Overdue": Entrepreneur Kiran Mazumdar Shaw
September 18, 2023 1:38
World Health Day Special: Kiran Mazumdar Shaw On How Can India Achieve Health For All
April 06, 2023 8:38
Kiran Mazumdar Shaw's World Health Day Message
April 06, 2023 0:34
"I Don't Worry": Kiran Shaw Assures Bright Future For 'Agniveers'
June 20, 2022 2:36
"Agniveers Will Have Distinct Advantage In Job Market": Biocon's Kiran Shaw
June 20, 2022 5:42
Kiran Mazumdar Shaw On Budget Disappointments
February 01, 2022 8:16
"Shouldn't Overreact To Delays In Covaxin Approval": Biocon's Kiran Shaw To NDTV
November 03, 2021 25:09
Equitable Access To Vaccines Important: Kiran Mazumdar Shaw
May 06, 2021 12:20
Covid-19 Vaccine Pricing: Private Risk Or Public Funding?
April 30, 2021 4:20
'One Nation, Many Prices' Policy Sparks Controversy
April 30, 2021 2:50
Outrage Grows Over Vaccine Rate Cards
April 30, 2021 3:17
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination